Skip to content

RNTX RNTX PP&E (Net)

PP&E (Net) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$7.66B+6.2%
Gilead Sciences logo
Gilead SciencesGILD
$5.64B+4.0%
AbbVie logo
AbbVieABBV
$5.69B+8.6%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$4.24M-9.5%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$23.57M+0.2%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$177K

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: RNTX’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's PP&E (net)?
RNTX (RNTX) reported PP&E (net) of $0 in Q4 2025.
How has RNTX's PP&E (net) changed year-over-year?
RNTX's PP&E (net) decreased by 100.0% year-over-year, from $1K to $0.
What is the long-term trend for RNTX's PP&E (net)?
Over 5 years (2020 to 2025), RNTX's PP&E (net) has grown at a -100.0% compound annual growth rate (CAGR), from $15K to $0.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.